Literature DB >> 16041366

High-throughput generation of small antibacterial peptides with improved activity.

Kai Hilpert1, Rudolf Volkmer-Engert, Tess Walter, Robert E W Hancock.   

Abstract

Cationic antimicrobial peptides are able to kill a broad variety of Gram-negative and Gram positive bacteria and thus are good candidates for a new generation of antibiotics to treat multidrug-resistant bacteria. Here we describe a high-throughput method to screen large numbers of peptides for improved antimicrobial activity. The method relies on peptide synthesis on a cellulose support and a Pseudomonas aeruginosa strain that constitutively expresses bacterial luciferase. A complete substitution library of 12-amino-acid peptides based on a linearized variant (RLARIVVIRVAR-NH(2)) of the bovine peptide bactenecin was screened and used to determine which substitutions at each position of the peptide chain improved activity. By combining the most favorable substitutions, we designed optimized 12-mer peptides showing broad spectrum activities with minimal inhibitory concentrations (MIC) as low as 0.5 microg/ml against Escherichia coli. Similarly, we generated an 8-mer substituted peptide that showed broad spectrum activity, with an MIC of 2 microg/ml, against E. coli and Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041366     DOI: 10.1038/nbt1113

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  100 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

Review 2.  Modulating immunity as a therapy for bacterial infections.

Authors:  Robert E W Hancock; Anastasia Nijnik; Dana J Philpott
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

3.  Short cationic antimicrobial peptides interact with ATP.

Authors:  Kai Hilpert; Brett McLeod; Jessie Yu; Melissa R Elliott; Marina Rautenbach; Serge Ruden; Jochen Bürck; Claudia Muhle-Goll; Anne S Ulrich; Sandro Keller; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

Review 4.  Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold.

Authors:  Brandon Findlay; George G Zhanel; Frank Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

5.  Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity.

Authors:  A K Marr; S Cen; R E W Hancock; W R McMaster
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

6.  High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides.

Authors:  Evan F Haney; Sarah C Mansour; Ashley L Hilchie; César de la Fuente-Núñez; Robert E W Hancock
Journal:  Peptides       Date:  2015-03-31       Impact factor: 3.750

Review 7.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  High-throughput and facile assay of antimicrobial peptides using pH-controlled fluorescence resonance energy transfer.

Authors:  Young Soo Kim; Hyung Joon Cha
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

9.  Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.

Authors:  Christof Junkes; Richard D Harvey; Kenneth D Bruce; Rudolf Dölling; Mojtaba Bagheri; Margitta Dathe
Journal:  Eur Biophys J       Date:  2011-02-01       Impact factor: 1.733

10.  The role of hydrophobicity in the antimicrobial and hemolytic activities of polymethacrylate derivatives.

Authors:  Kenichi Kuroda; Gregory A Caputo; William F DeGrado
Journal:  Chemistry       Date:  2009       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.